Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response

Authors

  • Olga Izmailova Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Oksana Shlykova Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Alina Kabaliei Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Anastasia Vatsenko Department of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine
  • Dmytro Ivashchenko Department of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine
  • Maksym Dudchenko Department of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine
  • Andrii Volianskyi Laboratory of Immunorehabilitology, Mechnikov Institute of Microbiology and Immunology, Kharkiv, Ukraine
  • Gennadiy Zelinskyy Institute for Virology, University Medicine Essen, University Duisburg-Essen, Germany
  • Tetiana Koval Department of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine
  • Ulf Dittmer Institute for Virology, University Medicine Essen, University Duisburg-Essen, Germany
  • Igor Kaidashev Department of Internal Medicine No3 with Phthisiology, Poltava State Medical University, Poltava, Ukraine

Keywords:

COVID-19, Ukrainian population, tmprss2 (rs12329760)

Abstract

.

References

Kaidashev I, Izmailova O, Shlykova O, et al. Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population. Acta Biomed. 2023 Feb 13;94(1):e2023030. doi: 10.23750/abm.v94i1.13543.

Kaidashev I, Shlykova O, Izmailova O, et al. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon. 2021;7(8):e07863. doi:10.1016/j.heliyon.2021.e07863.

Izmailova O, Shlykova O, Vatsenko A, et al. Allele С (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population. Infect Genet Evol. 2022;98:105227. doi:10.1016/j.meegid.2022.105227.

da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021 Apr;133(7-8):377-382. doi: 10.1007/s00508-020-01760-4.

Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020 Jun 5;9(6):1753. doi: 10.3390/jcm9061753.

Patel VK, Shirbhate E, Rajak H. Coronavirus reinfections: An outlook on evidences and effects. Lessons from COVID-19. 2022:19–40. doi: 10.1016/B978-0-323-99878-9.00013-3.

Downloads

Published

24-04-2023

Issue

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

How to Cite

1.
Izmailova O, Shlykova O, Kabaliei A, et al. Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response. Acta Biomed. 2023;94(2):e2023109. doi:10.23750/abm.v94i2.14423